Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex

Go back to Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex
PARTNERRE LTD. (NASDAQ: PRE) Delayed: 24.47 -1.15 (4.49%)
Previous Close $25.62    52 Week High $141.25 
Open $25.50    52 Week Low $111.52 
Day High $25.96    P/E 2.31 
Day Low $24.40    EPS $10.58 
Volume 77,166       

PARTNERRE LTD. (NASDAQ: PRE) Delayed: 24.47 -1.15 (4.49%)
Previous Close $25.62    52 Week High $141.25 
Open $25.50    52 Week Low $111.52 
Day High $25.96    P/E 2.31 
Day Low $24.40    EPS $10.58 
Volume 77,166       

PARTNERRE LTD. (NASDAQ: PRE) Delayed: 24.47 -1.15 (4.49%)
Previous Close $25.62    52 Week High $141.25 
Open $25.50    52 Week Low $111.52 
Day High $25.96    P/E 2.31 
Day Low $24.40    EPS $10.58 
Volume 77,166